IL10 and polycystic ovary syndrome: These results suggest that BM-hMSC can ameliorate PCOS-induced inflammation through IL-10 secretion, and IL-10-overexpressing BM-hMSC might be a novel and robust therapeutic approach for PCOS treatment (Fig. 6h).